To request further information on the ASTRAL trial please use the details below.
Mrs Elizabeth Brettell, Trial Manager
+44 (0)121 415 9130
Miss Charmaine Meek, Trial Administrator
+44 (0)121 415 9132
Miss Gemma Ryan, Data Manager
+44 (0)121 415 9134
Miss N Ives, Senior Statistician
+44 (0)121 415 9113
Main BCTU switchboard: 0121 415 9100
Fax: +44 (0)121 415 9135
Kidney Research UK
The Journal of Renovascular Disease
British Society of Interventional Radiology
UK Interventional Radiology Course
Find out more information about our other renal trials and the University of Birmingham Clinical Trials Unit below:
The University of Birmingham Clinical Trials Unit (BCTU) is a Research Unit within the School of Medicine specialising in the design, conduct and analysis of clinical trials.
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: an international randomised controlled trial.
PREDNOS is a national multi centre randomised double blind trial of long-term tapering versus standard prednisolone (steroid) therapy for the treatment of the initial episode of childhood nephrotic syndrome.
GloMY is a national, multi-centre, randomised controlled open-label pilot trial of Myfortic plus short course steroids versus standard care in patients with proteinuric primary focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN).
PREDNOS 2 is a phase III randomised parallel group, placebo-controlled, double-blind trial of short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome.
STOP-ACEi is a multi-centre, randomised controlled trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced kidney disease.